Drawing for OURLOOP

USPTO serial 79198074

OURLOOP

Reviewed by CopyMark Law Group

Reg. 5537615Status 709
Filing date
Status date
Registration date
Aug 14, 2018
Examiner
HENRY, NAKIA D
Law office
TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OURLOOP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive impairment, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and dependency; diagnostic preparations, substances, reagents and agents for medical purposes; pharmaceuticals for treatment of cognitive disordersSECTION 71 - CANCELLED—
009Downloadable electronic publications in the nature of books, reports, brochures, booklets, leaflets, patient information leaflets, magazines, journals, teaching and educational material in the field of clinical, medical, pharmaceutical or clinical or medical diagnostic research and development, clinical tests, clinical or medical diagnostic, medicine, pharmaceuticals, medical disorders, medical diseases, clinical or medical treatment and prevention; application software for mobile devices for clinical or medical diagnostic purposes relating to mental or behavioral health; downloadable electronic publications in the nature of brochures, books, magazines related to assessment of cognitive functions; applications software for mobile devices for assessment of cognitive functions; downloadable software for assessment of cognitive functions; software application for measuring psychical and mental health; software used as an installation tool for software applications to retrieve data which is sent automaticallySECTION 71 - CANCELLED—
010Surgical and medical apparatus and instruments; diagnostic apparatus and instruments for medical purposes for monitoring patient behavior and medication compliance; integrated medical systems containing medical instruments and software for information and information management for use of a Web-based physical and psychological and neurological examination and assessment of patients and clients at a distance and at a clinic; medical instruments for information, guidance and control of medicinesSECTION 71 - CANCELLED—
041Education in the nature classes, seminars, workshops in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; providing of training in the form of courses, seminars, workshops in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; arranging and conducting seminars, conferences, symposiums, workshops and courses in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; educational services in the nature of classes, seminars, and workshops, and training services in the field of research and development, science, clinical tests, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention related to assessment of cognitive functions; providing the aforementioned services electronically, on-line, via Internet or other electronic media; arranging and conducting expert in person educational forums in the field of clinical, medical, pharmaceutical and medical diagnostic research and development; on-line training programs in the form of courses, seminars, workshops in the field of research and development, science, clinical tests, diagnostic medicine, pharmaceuticals, and with regard to disorders, diseases, treatment and prevention related to assessment of cognitive functions; providing on-line, non-downloadable publications, namely, books, reports, brochures, booklets, patient information leaflets, magazines, journals, teaching and educational material in the field of research and development, science, clinical tests, diagnostic medicine, pharmaceuticals with regard to disorders, diseases, treatment and prevention related to assessment of cognitive functionsSECTION 71 - CANCELLED—
042Pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, medical diseases and medical treatment; scientific and technological services, namely, research in the field of the central nervous system and related disorders, diseases and pharmaceuticals related thereto; medical research and tests in the field of assessment of cognitive functions for mental or behavioral ill health; clinical research and tests in the field of the assessment of cognitive functions; providing online non-downloadable screening software for assessment of cognitive functionsSECTION 71 - CANCELLED—
044Medical and healthcare services, namely, providing medical clinics providing assessment of cognitive functions and therapeutic services, namely, the treatment of cognitive disorders and diseases; medical services in the field of psychiatry and psychology and diagnosis and treatment of central nervous system diseases and disorders; medical advice related to medical and pharmaceutical preparations and substances; healthcare and medical services related to central nervous system and brain disorders; providing medical and medicinal information in the field of diagnostics, pharmaceuticals, disorders, diseases, treatment and prevention; providing on-line medical data and analyses designed to provide patients with customized information, including information regarding medical dose, diagnosis, therapeutic issues; remote monitoring of data relating to patients health and diagnostics all offered via an Internet portal or an interactive platformSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
May 2, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 2, 2026INPCINVALIDATION PROCESSED—
Oct 28, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 28, 2025C71TCANCELLED SECTION 71—
Aug 14, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 21, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 4, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 4, 2018FIMPFINAL DISPOSITION PROCESSED—
Nov 14, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 14, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 1, 2018OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 29, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 29, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 25, 2018GPNXNOTIFICATION PROCESSED BY IB—
May 16, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 16, 2018OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 9, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 9, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 20, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 13, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 13, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 6, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 24, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 24, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 8, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 24, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jul 24, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 24, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 24, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 14, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 7, 2017ALIEASSIGNED TO LIE—
Jun 5, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 8, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 30, 2017CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 30, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 30, 2016RFRRREFUSAL PROCESSED BY MPU—
Dec 27, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 26, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 19, 2016DOCKASSIGNED TO EXAMINER—
Dec 19, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance